ProCE Banner Activity

Available and Emerging Treatment Options in IDH-Mutant AML

Slideset Download
Conference Coverage
Download this slideset from a live ASH symposium reviewing the latest treatment approaches, including newly approved agents, for patients with IDH-mutated AML.

Released: December 05, 2018

Expiration: December 04, 2019

Share

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by educational grants from

Actinium

Astellas Text

Boston Biomedical

Celgene

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation